Telomir Pharmaceuticals, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TELO and other ETFs, options, and stocks.About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ.
TELO Key Statistics
Stock Snapshot
Telomir Pharmaceuticals, Inc.(TELO) stock is priced at $1.18, giving the company a market capitalization of 81.15M. It carries a P/E multiple of -4.05.
On 2026-08-06, Telomir Pharmaceuticals, Inc.(TELO) stock moved within a range of $1.13 to $1.21. With shares now at $1.18, the stock is trading +4.4% above its intraday low and -2.5% below the session's peak.
Trading volume for Telomir Pharmaceuticals, Inc.(TELO) stock has reached 74.64K, versus its average volume of 82.2K.
Over the past 52 weeks, Telomir Pharmaceuticals, Inc.(TELO) stock has traded between a high of $2.09 and a low of $0.89.
Over the past 52 weeks, Telomir Pharmaceuticals, Inc.(TELO) stock has traded between a high of $2.09 and a low of $0.89.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.